Lifeline Cell Technology
Blood & Organ Banks · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8415 Progress Dr Unit T, Frederick, Mary...Phone Number
(760) 653-1216Website
www.lifelinecelltech.comRevenue
<$5 MillionIndustry
About Lifeline Cell Technology
Lifeline Cell Technology Org Chart
Is Lifeline Cell Technology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Lifeline Cell Technology, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Lifeline Cell Technology had a recent Job posting/layoffs
Check out if Lifeline Cell Technology is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Lifeline Cell Technology
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Lifeline Cell Technology launches new products
Earning: See what the market has to say on Lifeline Cell Technology recently announced quarterly report
Funding: Get notified immidiatlly once Lifeline Cell Technology has new funding data
Check if Lifeline Cell Technology has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Lifeline Cell Technology as Masked Content
Find 2 more new buyers
Compare Similar Companies to Lifeline Cell Technology
Compare insights from companies similar to Lifeline Cell Technology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Lifeline Cell Technology is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Lifeline Cell Technology is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Lifeline Cell Technology.
Lifeline Cell Technology Tech Stack
A closer look at the technologies used by Lifeline Cell Technology
Lifeline Cell Technology News & Media
International Stem Cell Corporation Treated Real Estate Icon Kevin Weeks
CARLSBAD, Calif., Jan. 11, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products reported today that Kevin Weeks, a real estate icon, who underwent neural stem cell treatment in ISCO Parkinson’s disease clinical trial, recently issued a video thanking the neurosurgeons who perfoInternational Stem Cell Corporation Treated Real Estate Icon Kevin Weeks
CARLSBAD, Calif., Jan. 11, 2018 (GLOBE NEWSWIRE) -- via Network NewsWire – International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products reported today that Kevin Weeks, a real estate icon, who underwent neural stem cell treatment in ISCO Parkinson’s disease clinical trial, recently issued a video thanking the neurosurgeons who pInternational Stem Cell Corporation Doses 7th Patient in Clinical Trial for Parkinson's Disease
CARLSBAD, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products reported today that a third patient of the second cohort with Parkinson's disease was successfully transplanted with ISCO's proprietary ISC-hpNSC® cells. The operation was successfully performed by the team of the RoyInternational Stem Cell Corporation Doses 7th Patient in Clinical Trial for Parkinson's Disease
CARLSBAD, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products reported today that a third patient of the second cohort with Parkinson's disease was successfully transplanted with ISCO's proprietary ISC-hpNSC® cells. The operation was successfully performed by the team of the Roy
Top Blood & Organ Banks Companies
Frequently Asked Questions Regarding Lifeline Cell Technology
Lifeline Cell Technology specializes in providing primary human cells, stem cells, and optimized media designed for scientific research. With over 25 years of experience, they offer a diverse range of high-quality primary cells and tailored media solutions, enhancing research outcomes for their clients. Their products cater to various applications... Read More